Crowdonomics
Medical 21, Inc.

Reg A+ · Equity · Mar 2022

ClosedReg A+Equity
via the platform · last checked Aug 16, 2026
Raised
$4M / $40M max
10% of ceiling
Investors
—
—
Estimated pre-money
$115.8M
—

Financials disclosed in this offering

FY2020 · hover for source
$0
−$3.9M
FY2020
RevenueNet income
Metric
FY2020 audited
Income statement
Revenue
$0
Cost of goods sold
$3,860,545
Net income
-$3,860,246
Balance sheet
Cash
$3,514,121
Accounts receivable
$0
Total assets
$4,640,554
Long-term debt
$0
Total liabilities
$150,306
Other
Headcount
7

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

3 amendments
  1. Jun 22, 2022
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  2. Apr 22, 2022
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  3. Apr 22, 2022
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Est. pre-money$115.8M
Price / share$5.80
Shares offered6,896,551

Estimated, not stated: $5.80 × 19,965,830 securities outstanding.

Offering details

Target—
Max$40,000,000
Min investment—
OpenedMar 10, 2022
Deadline—
ClosedMay 22, 2023
Days active438

Links & provenance

Source: SEC EDGAR
0001673688-22-000003
Last synced Aug 16, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.